Sulfide Quinone Oxidoreductase Alleviates Acute Ulcerative Colitis by Regulating Mitochondrial Dysfunction
MedComm · 2025-07 · 6 (7)
DOI: 10.1002/mco2.70285 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 13.07.2025. Verfasst von Hailin Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences Nanjing University Nanjing PR China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Alteration in mitochondrial function within intestinal epithelial cells were closely related to inflammatory bowel disease (IBD) progression. Sulfide quinone oxidoreductase ( SQOR ), located in the inner mitochondria membrane, is a crucial enzyme in sulfide metabolism. Here, we observed that SQOR was downregulated during colitis. Intestinal epithelial cells specific knockout of SQOR ( Sqor CKO ) mice were more susceptible to acute ulcerative colitis (UC) with lower hydrogen sulfide (H 2 S) levels, and the absence of SQOR caused a breakdown of the epithelial barrier through disruption of the tight junction proteins. Furthermore, analysis of the mitochondrial morphology and functions revealed increased mitochondrial damage when SQOR deficiency. Mechanistically, it is observed that SQOR knockout increased lipid peroxidation, malondialdehyde (MDA) levels and ferroptosis. Further results demonstrated that SQOR may rely on inhibiting excessive mitochondrial division and promoting mitochondrial biogenesis to regulate reaction oxygen species (ROS) levels in intestinal epithelial cells. Treatment with ROS scavengers (NAC) showed significant reduced colonic inflammation symptoms observed in DSS‐treated Sqor CKO mice. Collectively, these findings demonstrate the protective role of SQOR in intestinal epithelial cells in maintaining mitochondrial homeostasis by regulating ROS and providing novel insight into UC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences Nanjing University Nanjing PR China.
- Jiangsu Key Laboratory of Neuropsychiatric Diseases & Institute of Neuroscience Soochow University Suzhou PR China.
- Changzhou High-Tech Research Institute of Nanjing University and Jiangsu Target Pharma Laboratories Inc. Changzhou PR China.
- Faculty of Pharmaceutical Sciences Xinxiang Medical University Xinxiang PR China.
Förderung
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Ma, H., Fu, S., Huang, C., Han, N., Cai, F., Li, D., Cheng, J., Zhuang, H., & Hua, Z. C. (2025). Sulfide Quinone Oxidoreductase Alleviates Acute Ulcerative Colitis by Regulating Mitochondrial Dysfunction. MedComm, 6(7). https://doi.org/10.1002/mco2.70285
Vancouver
Ma H, Fu S, Huang C, Han N, Cai F, Li D, et al. Sulfide Quinone Oxidoreductase Alleviates Acute Ulcerative Colitis by Regulating Mitochondrial Dysfunction. MedComm. 2025;6(7). doi:10.1002/mco2.70285
BibTeX
@article{Ma2025,
author = {Ma, Hailin and Fu, Shuilian and Huang, Chujun and Han, Na and Cai, Fangfang and Li, Dangran and Cheng, Jian and Zhuang, Hongqin and Hua, Zi-Chun},
title = {Sulfide Quinone Oxidoreductase Alleviates Acute Ulcerative Colitis by Regulating Mitochondrial Dysfunction},
journal = {MedComm},
year = {2025},
volume = {6},
number = {7},
doi = {10.1002/mco2.70285}
}
EUVIMED